N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in order to explore better subtypes of CCB for the tr...

Full description

Bibliographic Details
Main Authors:	Mingming Zhao, Ziyan Zhang, Zhiyu Pan, Sijia Ma, Meiying Chang, Jiao Fan, Shunxuan Xue, Yuejun Wang, Hua Qu, Yu Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Pharmaceuticals
Subjects:	N-type calcium channel blocker T-type calcium channel blocker L-type calcium channel blocker chronic kidney disease proteinuria
Online Access:	https://www.mdpi.com/1424-8247/16/3/338

Similar Items

Corrected QT interval in electrocardiogram recordings in patients treated with calcium channel blockers
by: Małgorzata Wołek, et al.
Published: (2023-06-01)

Calcium-channel blockers for the prevention of stroke: from scientific evidences to the clinical practice
by: S. Taddei
Published: (2013-05-01)

Calcium Channel Blocker Overdose Simulation
by: Michael Maniaci, et al.
Published: (2015-01-01)

Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
by: Prabhakar Adake, et al.
Published: (2015-01-01)

Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
by: Dan Wang, et al.
Published: (2022-07-01)

Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
by: G Agnes Golda Priyadarshini, et al.
Published: (2023-01-01)

Inhibition of N-Type Calcium Channels by Fluorophenoxyanilide Derivatives
by: Ellen C. Gleeson, et al.
Published: (2015-04-01)

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease
by: Dominik G. Haider, et al.
Published: (2015-12-01)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
by: Maddalena Ardissino, et al.
Published: (2022-09-01)

Once was not enough: A case report of the concomitant intoxication of amlodipine (calcium channel blocker) and clonazepam (benzodiazepine)
by: Swotantra Gautam, et al.
Published: (2022-07-01)

Effect of calcium channel blockers on gingival tissues in hypertensive patients in Lagos, Nigeria: A pilot study
by: Kehinde Adesola Umeizudike, et al.
Published: (2017-01-01)

Calcium Channels in the Heart: Disease States and Drugs
by: Kajol Shah, et al.
Published: (2022-03-01)

Discovery and Development of Calcium Channel Blockers
by: Théophile Godfraind
Published: (2017-05-01)

Penggunaan Calcium Channel Blocker pada Tatalaksana Anestesi Clipping Aneurisma Otak
by: Fanda Ayyu Rindiati, et al.
Published: (2019-10-01)

Calcium channel blockers: more than 50 years on guard of health
by: I E Chazova, et al.
Published: (2015-06-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Outcomes following calcium channel blocker exposures reported to a poison information center
by: Mikkel B. Christensen, et al.
Published: (2018-11-01)

New Conotoxin SO-3 Targeting N-type Voltage-Sensitive Calcium Channels
by: Lei Wen, et al.
Published: (2006-04-01)

Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices
by: Hongtao Tie, et al.
Published: (2024-02-01)

The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients
by: Takayasu Ito, et al.
Published: (2019-01-01)

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions
by: Oyku Gulmez, et al.
Published: (2008-12-01)

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
by: Venu Gopal Jonnalagadda, et al.
Published: (2017-12-01)

Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study
by: Tamara Theiner, et al.
Published: (2024-12-01)

Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model
by: Hidekazu Tsuruga, et al.
Published: (2023-03-01)

Laporan kasus berbasis bukti: Efektifitas Pemberian Calcium Channel Blocker pada Perdarahan Subaraknoid Akibat Trauma Kepala
by: Irawan Mangunatmadja, et al.
Published: (2020-12-01)

Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension
by: Bruna Piloto, et al.
Published: (2023-05-01)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
by: Sang-Ho Jo, et al.
Published: (2018-06-01)

Design, Synthesis, Pharmacodynamic and <i>In Silico</i> Pharmacokinetic Evaluation of Some Novel Biginelli-Derived Pyrimidines and Fused Pyrimidines as Calcium Channel Blockers
by: Ahmed M. Farghaly, et al.
Published: (2022-03-01)

Calcium channel blocker induced gingival enlargement following implant placement in a fibula free flap reconstruction of the mandible: a case report
by: Henry Quach, et al.
Published: (2020-08-01)

Renoprotective effect of calcium channel blockers
by: Dimković Nada, et al.
Published: (2009-01-01)

T-Type Calcium Channels: A Mixed Blessing
by: Dario Melgari, et al.
Published: (2022-08-01)

Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina
by: Sung Eun Kim, et al.
Published: (2021-01-01)

N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain
by: Shikha Choudhary, et al.
Published: (2023-02-01)

The Long-term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension
by: Azam Kiani, et al.
Published: (2023-01-01)

Calcium Channel Blocker Toxicity: A Practical Approach
by: Alshaya OA, et al.
Published: (2022-08-01)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
by: Junxiong Lin, et al.
Published: (2023-05-01)

A New Computer Model for Evaluating the Selective Binding Affinity of Phenylalkylamines to T-Type Ca<sup>2+</sup> Channels
by: You Lu, et al.
Published: (2021-02-01)

Long-acting nifedipine in the management of the hypertensive patient
by: Morgan E Snider, et al.
Published: (2008-12-01)

Amlodipine: its ability to reduce the risk of complications of arterial hypertension
by: Nadezhda Konstantinovna Runikhina, et al.
Published: (2009-12-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)